Zejia Yang

905 total citations
16 papers, 740 citations indexed

About

Zejia Yang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zejia Yang has authored 16 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zejia Yang's work include NF-κB Signaling Pathways (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer-related Molecular Pathways (4 papers). Zejia Yang is often cited by papers focused on NF-κB Signaling Pathways (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer-related Molecular Pathways (4 papers). Zejia Yang collaborates with scholars based in United States and China. Zejia Yang's co-authors include Kevin J. Cullen, Lisa M. Schumaker, Zhongmin Guo, Merrill J. Egorin, Eleanor G. Zuhowski, Kenneth Newkirk, Charles M. Rudin, David James VanderWeele, Rena G. Lapidus and Jipei Liao and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and Oncotarget.

In The Last Decade

Zejia Yang

16 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zejia Yang United States 11 450 239 141 127 66 16 740
Kishore Polireddy United States 13 331 0.7× 155 0.6× 206 1.5× 118 0.9× 65 1.0× 27 876
Rossella Marullo United States 9 541 1.2× 270 1.1× 200 1.4× 160 1.3× 95 1.4× 18 969
Sherry Chow United States 7 468 1.0× 259 1.1× 88 0.6× 108 0.9× 84 1.3× 7 734
P Yue United States 9 521 1.2× 178 0.7× 54 0.4× 117 0.9× 42 0.6× 15 770
Naoki Wakimoto Japan 15 557 1.2× 199 0.8× 127 0.9× 90 0.7× 47 0.7× 29 947
Rhoda Arzoomanian United States 15 510 1.1× 319 1.3× 139 1.0× 160 1.3× 148 2.2× 27 947
Wanghai Zhang United States 11 387 0.9× 249 1.0× 68 0.5× 72 0.6× 67 1.0× 16 683
Stephen P. Fink United States 17 646 1.4× 256 1.1× 109 0.8× 292 2.3× 73 1.1× 31 1.1k

Countries citing papers authored by Zejia Yang

Since Specialization
Citations

This map shows the geographic impact of Zejia Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zejia Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zejia Yang more than expected).

Fields of papers citing papers by Zejia Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zejia Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zejia Yang. The network helps show where Zejia Yang may publish in the future.

Co-authorship network of co-authors of Zejia Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zejia Yang. A scholar is included among the top collaborators of Zejia Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zejia Yang. Zejia Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yang, Zejia, Xiaoxuan Fan, Yong Teng, et al.. (2025). Evaluation of co‑inhibition of ErbB family kinases and PI3K for HPV‑negative head and neck squamous cell carcinoma. Oncology Reports. 53(3). 2 indexed citations
2.
3.
Yang, Zejia, Jipei Liao, Lisa M. Schumaker, et al.. (2022). Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma. Oral Oncology. 131. 105939–105939. 8 indexed citations
4.
Yang, Zejia, et al.. (2022). An Unsupervised Facial Expression Recognition Method Based on CycleGAN. 36. 669–674. 2 indexed citations
5.
Yang, Zejia, Jipei Liao, Rena G. Lapidus, et al.. (2022). Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma. Cancer Chemotherapy and Pharmacology. 89(4). 469–478. 4 indexed citations
6.
Liao, Jipei, Zejia Yang, Brandon Carter‐Cooper, et al.. (2020). Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition. Clinical & Experimental Metastasis. 37(2). 283–292. 15 indexed citations
7.
Yang, Zejia, Jipei Liao, Kevin J. Cullen, & Hancai Dan. (2020). Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma. Cell Death Discovery. 6(1). 36–36. 11 indexed citations
8.
Yang, Zejia, Jipei Liao, Brandon Carter‐Cooper, et al.. (2019). Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway. BMC Cancer. 19(1). 485–485. 32 indexed citations
9.
Lin, Xiaofeng, Jipei Liao, Zejia Yang, et al.. (2019). Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitor.. PubMed. 9(6). 1282–1292. 16 indexed citations
10.
Li, Zhipeng, Jipei Liao, Zejia Yang, et al.. (2018). Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer. British Journal of Cancer. 120(3). 306–316. 13 indexed citations
11.
Li, Zhipeng, Zejia Yang, Antonino Passaniti, et al.. (2016). A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-κB regulates head and neck squamous cell carcinoma proliferation. Oncotarget. 7(22). 31892–31906. 53 indexed citations
12.
Li, Zhipeng, Zejia Yang, Rena G. Lapidus, et al.. (2015). IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancer.. PubMed. 5(10). 3098–110. 15 indexed citations
13.
Cullen, Kevin J., Zejia Yang, Lisa M. Schumaker, & Zhongmin Guo. (2007). Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer. Journal of Bioenergetics and Biomembranes. 39(1). 43–50. 149 indexed citations
14.
Yang, Zejia, Lisa M. Schumaker, Merrill J. Egorin, et al.. (2006). Cisplatin Preferentially Binds Mitochondrial DNA and Voltage-Dependent Anion Channel Protein in the Mitochondrial Membrane of Head and Neck Squamous Cell Carcinoma: Possible Role in Apoptosis. Clinical Cancer Research. 12(19). 5817–5825. 219 indexed citations
15.
Rudin, Charles M., Zejia Yang, Lisa M. Schumaker, et al.. (2003). Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.. PubMed. 63(2). 312–8. 157 indexed citations
16.
Yang, Zejia, Patrick J. Faustino, Paul A. Andrews, et al.. (2000). Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines. Cancer Chemotherapy and Pharmacology. 46(4). 255–262. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kishore Polireddy Breakdown of academic impact, for papers by Rossella Marullo Breakdown of academic impact, for papers by Sherry Chow Breakdown of academic impact, for papers by P Yue Breakdown of academic impact, for papers by Naoki Wakimoto Breakdown of academic impact, for papers by Rhoda Arzoomanian Breakdown of academic impact, for papers by Wanghai Zhang Breakdown of academic impact, for papers by Stephen P. Fink
Rankless by CCL
2026